Researchers have created a plan for a future study to see if one combination of blood-thinning drugs works better than another for people who have had a minor stroke. The study will focus on patients who had a minor ischemic stroke, which is a stroke caused by a blocked blood vessel in the brain. Their stroke symptoms were mild, with a score of 5 or less on a standard scale, and they will be enrolled within 72 hours of their symptoms starting.
The study will take place at four medical centers in China and will include 464 patients. One group will receive the drug argatroban along with clopidogrel. The other group will receive the more common combination of aspirin plus clopidogrel. The main goal is to see which group has more people with an excellent recovery, meaning minimal or no disability, 90 days after their stroke.
It is very important to understand that this document only describes the plan for the study. The research has not been completed, so there are no results to report. We do not know if one treatment is better, safer, or has fewer side effects. The study is designed to find that out. Readers should know this is a look at a research plan, not a report of findings. The real value will come when the study is finished and the results are published.